References
- Regunathan S, Evinger MJ, Meeley MP, et al. Effects of clonidine and other imidazoline-receptor binding agents on second messen-ger systems and calcium influx in bovine adrenal medulla chromafin cells. Biochem Pharmacol 1991; 42: 2011–2018
- Regunathan S, Feinstein DL, Reis DJ. Expression of non-adrenergic imidazoline sites in rat cerebral cortical astrocytes. I Neurosci Res 1993; 34: 681–688
- Regunathan S, Reis DJ. Imidazoline receptors and their endogen-ous ligands. Annu Rev Pharmacol Toxicol 1996; 36: 511–544
- Tesson F, Limon-Boulez I, Urban P, et al. Localization of 12-imidazoline binding sites on monoamine oxidases. J Biol Chem 1995; 270: 9856–9861
- Raddatz R, Parini A, Lanier SM. Imidazoline/guanidinium binding domains on monoamine oxidases. Relationship to subtypes of imidazoline-binding proteins and tissue-specific interaction of imidazoline ligands with monoamine oxidase B. I Biol Chem 1995; 270: 27961–27968
- Casanovas A, Olmos G, Ribera J, et al. Induction of reactive astrocytosis and prevention of motoneuron cell death by the 12-imidazoline receptor I igand LSL 60101. Br] Pharmaco 12000; 130: 1767-1776
- Gargalidis-Moudanos C, Remaury A, Pizzinat N et al. Predominant expression of monoamine oxidase B isoform in rabbit renal proximal tubule: Regulation by 12 imidazoline ligands in intact cells. Mol Pharmacol 1997; 51: 637–643
- Tesson F, Prip-Buus C, Lemoine A, et al. Subcellular distribution of imidazoline—guanidinium-receptive sites in human and rabbit liver. J Biol Chem 1991; 266: 155–160
- Hosseini AR, King PR, Louis WJ, et al. 13H12-(2-benzofurany1)-2-imidazoline, a highly selective radioligand for I2-imidazoline receptor binding sites. Studies in rabbit kidney membranes. Naunyn Schmiedebergs Arch Pharmacol 1997; 355: 131–138
- Lione LA, Nutt DJ, Hudson AL. 13H12-(2-benzofurany1)-2-imidazo-line: A new selective high affinity radioligand for the study of rabbit brain imidazoline 12 receptors. Eur J Pharmacol 1996; 304: 221–229
- Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in the rats. Stroke 1989; 20: 84–91
- Swanson RA, Morton MT, Tsao-Wu G, et al. A semiautomated method for measuring brain infarct volume. I Cereb Blood Flow Metab 1990; 10: 290–293
- Maiese K, Pek L, Berger SB, et al. Reduction in focal cerebral ischemia by agents acting at imidazole receptors. I Cereb Blood Flow Metab 1992; 12: 53–63
- Ozog MA, Wilson JX, Dixon SJ, et al. Rilmenidine elevates cytosolic free calcium concentration in suspended cerebral astrocytes. I Neurochem 1998; 71: 1429–1435
- Olmos G, Alemany R, Escriba PV, et al. The effects of chronic imidazoline drug treatment on glial fibrillary acidic protein concentrations in rat brain. Br] Pharmacol 1994; 111: 997–1002
- Alemany R, Olmos G, Escribá PV, et al. LSL 60101, a selective ligand for 12 receptors, on glial fibrillary acidic protein concentra-tion. Eur J Pharmacol 1995; 280: 205–210
- Ozaita A, Olmos G, Boronat MA, et al. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver. Br] Pharmacol 1997; 121: 901–912
- Raasch W, Muhle H, Dominiak P. Modulation of MAO activity by imidazoline and guanidine derivatives. Ann NY Acad Sci. 1999; 881: 313–331
- Suzuki T, Akaike N, Ueno K, et al. MAO inhibitors, clorgyline and lazabemide, prevent hydroxyl radical generation caused by brain ischemia/reperfusion in mice. Pharmacology 1995; 50: 357–362
- Seif-El-Nasr M, Atia AS, Abdelsalam RM. Effect of MAO-B inhibition against ischemia-induced oxidative stress in the rat brain. Comparison with a rational antioxidant. Arzneimittel-forschung 2008; 58: 160–167